Moreover, employing the dnFOS peptide, we could show that blocking AP-1 DNA binding activity blocked the proliferation of several AML sub-types in vitro and in vivo [23; 61; 65; 66; 67]. The gene discussed is FOS; the disease is acute myeloid leukemia.